Commercial Partners
If you are interested in sponsoring the American Drug Delivery & Formulation Summit, please contact:
Alexandra Krcho
Account Director
+ 44 (0)20 3874 9205
alexandra.krcho@markallengroup.com
2021 Commercial Partners
Adare Pharma Solutions
Adare Pharma Solutions is a global technology-driven specialty CDMO providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare’s technology platforms specialize in ODT, taste masking and customized drug release.
With over 30 years of proven legacy, Adare has successfully developed and manufactured more than 40 products sold by customers in more than 100 countries globally.
Arcinova
Arcinova is a Contract Development and Manufacturing Organization that helps pharmaceutical and biotechnology companies across the globe develop life changing medicines. We employ a multidisciplinary approach to drug development by combining the disciplines of chemistry, biology and bioinformatics. All our services are delivered from our 162,000ft2 facility in the North of England.
We leverage our decades of experience as a key research and development center for Sanofi and Covance to deliver high quality end-to-end solutions. Our mission is to deliver best-in-class technology services in the fields of contract research, development and small-scale manufacturing to overcome project challenges and increase efficiency.
Captisol
Captisol is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Captisol was invented and initially developed by scientists in the laboratories of Dr. Valentino Stella, University Distinguished Professor at the University of Kansas’ Higuchi Biosciences Center for specific use in drug development and formulation. This unique technology has enabled several FDA-approved products, including Amgen’s Kyprolis®, Baxter International’s Nexterone®, Spectrum’s EVOMELA® and Melinta Therapeutics’ Baxdela™. There are many Captisol-enabled products currently in various stages of development.
Croda
Established in 1925, Croda is the name behind high performance ingredients and technologies in some of the world’s biggest and most successful brands: creating, making and selling speciality chemicals that are relied on by industries and consumers everywhere. They have a network of over 4,500 passionate and committed employees, working together as one global team across manufacturing sites and offices in 38 countries. Within the Health Care market, Croda offers high purity pharmaceutical excipients, highly performing vaccine adjuvants and in-house formulation expertise, making them the ideal solutions provider with whom to navigate drug and vaccine formulation challenges. Their product portfolio is proven to solubilise, stabilise and deliver the most challenging of active pharmaceutical ingredients, while high investment in GMP and multi-site EXCiPACT accreditation demonstrates confidence in both excipient quality and supply chain security.
Gerresheimer
Gerresheimer is the global partner for pharmaceutics, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence and concentration on quality and customer focus. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer psroduces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.
Leon-Nanodrugs
Leon utilises its’ proprietary nano technology platform for the continuous manufacturing of SMART nanoparticles (ranging from surface stablilised polymeric through to lipid nanoparticles (LNP's) and liposomes). The Company is working with world class industry partners for both process and product development. Focused on process engineering solutions and combining with development and formulation expertise we expedite APIs (small and large molecules, NCE or established drug products) to deliver improved stability, increased solubility and enhanced bioavailability.
Lonza Pharma and Biotech
Lonza Pharma & Biotech provides global contract development and manufacturing services that enable pharma and biotech companies to bring medical innovations to patients in need. We are recognized for our reliability and high-quality, our global capacity, our innovative technology platforms, and our extensive experience. We have helped to commercialize pioneering therapies and we continuously invest and innovate to meet your expectations also for future medicines. Our belief is that the best outcome –for you and for your patients –comes as a result of a successful collaboration. Together, we can solve the next challenge and bring your next medicine to life.
MedinCell
MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment. The BEPO® technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for several days, weeks or months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. Based in Montpellier, MedinCell currently employs more than 130 people representing over 25 different nationalities.
Millipore Sigma
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.
Nanoform
Nanoform is an innovative nanoparticle medicine-enabling company that works together with global Pharma and biotech partners to devise solutions to complex formulation challenges. Nanoform’s multi-patented and scalable Controlled Expansion of Supercritical Solutions (CESS®) process can produce uniform nanoparticles as small as 10nm, facilitating transport even across biological barriers. As particles smaller than 100nm have significantly enhanced surface areas, this can increase drug dissolution rates and improve bioavailability, allowing drugs of poor solubility in the pharmaceutical pipeline to progress to clinical development. CESS® enables lower dosage and safer products to be developed with reduced side-effects and permits combination therapies, which would otherwise be prohibited by the large dosages of either drug. The award-winning technology is also ushering in a new era of ocular, pulmonary and transdermal drug delivery applications, along with enhanced delivery of drug particles across the blood-brain barrier.
PMC Isochem
PMC Isochem offers contract research, custom manufacturing, catalogue products and innovative solutions for Pharmaceutical companies worldwide.
- Drug delivery solutions: TPGS-1000 NF USP for poorly soluble drug formulation and Polyamino acid based solutions for Nano Encapsulation and Polymer Drug Conjugates
- CDMO services: GMP industrial exclusive custom synthesis and provides tailor made services from development to production. 3 FDA audited manufacturing plants
- Generic APIs: 20 generic API for US, EU and worldwide market
PTS
PTS specializes in the design and manufacturing of polyamino-acid based delivery systems and brings value to our delivering solutions to clinical development & commercialization of therapeutic assets.
PTS is a leader in the Design, Development & Custom Manufacturing of polyaminoacid-based Drug Substances and Drug Products (DP). Our company provides a comprehensive CMC package, including Preclinical Development, Technology Transfer, GMP Manufacturing and Fill&Finish.
Sonceboz
Our core competencies consist of design, development and production of mechatronic drive systems. Since 1936, our focus has been on innovation, best in class quality and service which is our key to success for worldwide OEM customers. Sonceboz is ISO 13485 certified and active in wearable drug delivery, medical devices and laboratory industry. Pharma companies looking for Large Volume Injectors for high viscosity drugs, Dual Cartridge or Auto-reconstitution Injectors will find interesting solutions in Sonceboz's new drug Delivery Device Platform. Customized technology modules like motor-drives, electronics, pumps and needle insertion systems are available for Medical device manufacturers. Address: Rue Rosselet Challandes - 5 2605 Sonceboz Switzerland
2020 Commercial Partners
Albumedix
Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. Dedicated to Better Health, we partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with more than 80 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.
Arcinova
Arcinova is a Contract Development and Manufacturing Organization that helps pharmaceutical and biotechnology companies across the globe develop life changing medicines. We employ a multidisciplinary approach to drug development by combining the disciplines of chemistry, biology and bioinformatics. All our services are delivered from our 162,000ft2 facility in the North of England.
We leverage our decades of experience as a key research and development center for Sanofi and Covance to deliver high quality end-to-end solutions. Our mission is to deliver best-in-class technology services in the fields of contract research, development and small-scale manufacturing to overcome project challenges and increase efficiency.
Captisol
Captisol is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Captisol was invented and initially developed by scientists in the laboratories of Dr. Valentino Stella, University Distinguished Professor at the University of Kansas’ Higuchi Biosciences Center for specific use in drug development and formulation. This unique technology has enabled several FDA-approved products, including Amgen’s Kyprolis®, Baxter International’s Nexterone®, Spectrum’s EVOMELA® and Melinta Therapeutics’ Baxdela™. There are many Captisol-enabled products currently in various stages of development.
Datwyler
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global healthcare world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure patient s’ safety and improve patients’ lives.
Foster Delivery Science
Foster Delivery Science focuses solely on Hot Melt Extrusion and extrusion processes to blend client API’s with polymers for several possible purposes: Solubility and bioavailability enhancement; create local delivery solutions such as drug loaded films, implants and fibers; create delivery or release profiles; and capture the powerful mixing capabilities of twin screw extruders. Operating from our new GMP facility 75 minutes from Boston in CT, we provide formulation development services, scale up, clinical trial material and ready for GMP manufacturing.
Gore & Associates
As a global materials science company, Gore collaborates with pharmaceutical companies to design materials-based solutions that fit their requirements for product purity, process effectiveness and device performance. Our newest innovation, the GORE ImproJect Plunger for pre-filled syringes protects sensitive biologics from silicone-induced particle formation and protein aggregation since Gore has eliminated the need for silicone in both the plunger and barrel.
Halo Labs
Halo Labs is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics. Horizon, its flagship product, can analyze sub visible particulate matter in biopharmaceutical samples to enable rapid particle screening as early as candidate selection and pre-formulation.
Lonza Pharma and Biotech
Lonza Pharma & Biotech provides global contract development and manufacturing services that enable pharma and biotech companies to bring medical innovations to patients in need. We are recognized for our reliability and high-quality, our global capacity, our innovative technology platforms, and our extensive experience. We have helped to commercialize pioneering therapies and we continuously invest and innovate to meet your expectations also for future medicines. Our belief is that the best outcome –for you and for your patients –comes as a result of a successful collaboration. Together, we can solve the next challenge and bring your next medicine to life.
MedinCell
MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment. The BEPO® technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for several days, weeks or months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. Based in Montpellier, MedinCell currently employs more than 130 people representing over 25 different nationalities.
Munit
MUNIT is a new and innovative consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.
In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership.
MUNIT is your direct access point to Jetpharma’s and Microchem’s services, such as:
- Jet- , Pin- and Hammer milling
- Co- and cryogenic micronization
- Sieving, Blending, De-Lumping
- Technical trials, DOE Studies, Process development and validation
- PSD analysis etc.
Nanoform
Nanoform is an innovative nanoparticle medicine-enabling company that works together with global Pharma and biotech partners to devise solutions to complex formulation challenges. Nanoform’s multi-patented and scalable Controlled Expansion of Supercritical Solutions (CESS®) process can produce uniform nanoparticles as small as 10nm, facilitating transport even across biological barriers. As particles smaller than 100nm have significantly enhanced surface areas, this can increase drug dissolution rates and improve bioavailability, allowing drugs of poor solubility in the pharmaceutical pipeline to progress to clinical development. CESS® enables lower dosage and safer products to be developed with reduced side-effects and permits combination therapies, which would otherwise be prohibited by the large dosages of either drug. The award-winning technology is also ushering in a new era of ocular, pulmonary and transdermal drug delivery applications, along with enhanced delivery of drug particles across the blood-brain barrier.
PMC Isochem
PMC Isochem offers contract research, custom manufacturing, catalogue products and innovative solutions for Pharmaceutical companies worldwide.
- Drug delivery solutions: TPGS-1000 NF USP for poorly soluble drug formulation and Polyamino acid based solutions for Nano Encapsulation and Polymer Drug Conjugates
- CDMO services: GMP industrial exclusive custom synthesis and provides tailor made services from development to production. 3 FDA audited manufacturing plants
- Generic APIs: 20 generic API for US, EU and worldwide market
Quotient Sciences
Quotient Sciences is a drug development services organization, dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform, which is proven to shorten development timelines and reduce associated costs.
Sonceboz
Our core competencies consist of design, development and production of mechatronic drive systems. Since 1936, our focus has been on innovation, best in class quality and service which is our key to success for worldwide OEM customers. Sonceboz is ISO 13485 certified and active in wearable drug delivery, medical devices and laboratory industry. Pharma companies looking for Large Volume Injectors for high viscosity drugs, Dual Cartridge or Auto-reconstitution Injectors will find interesting solutions in Sonceboz's new drug Delivery Device Platform. Customized technology modules like motor-drives, electronics, pumps and needle insertion systems are available for Medical device manufacturers. Address: Rue Rosselet Challandes - 5 2605 Sonceboz Switzerland
Other
Alcami
Alcami is a world-class fully integrated end-to-end contract development and manufacturing organization (CDMO) headquartered in North Carolina, with executive offices in Durham and Wilmington. With approximately 1,000 employees operating at 10 global locations, Alcami provides customizable and innovative services to small and mid-size pharmaceutical and biotechnology companies by offering individualized and integrated services across multiple areas. We connect our clients with innovative solutions for API development and manufacturing, solid-state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services. For more information, please visit alcaminow.com.
BDD
BDD is a specialist pharmaceutical development company providing expertise across all areas of drug delivery. Our service, customised to our clients individual needs, is inclusive of project design, optimal formulation development and lean clinical evaluation.
Our patented, time release technology - OralogiK™ provides unrivalled control of drug release in vivo – delivery at the right place, at the right time.
OralogiK™ enables the delivery of single, multi-dose or drug combinations at pre-determined times post dose. Benefits include:
• Chronotherapeutic oral drug delivery
• Target and effectively exploit Regional Absorption opportunities
• Lean clinical assessment of optimised formulations using BDD’s on site Clinical Unit”
Biopharma Group
Biopharma Group is a leading supplier of equipment and analytical services to the pharmaceutical, biotech and process industries for those using freeze drying technology, solvent removal/evaporation, high pressure homogenisation and industry related equipment. Our group compromises of dedicated divisions for:
- Sale and service of freeze drying and associated equipment throughout the UK, Ireland & France
- Independent R&D, analysis, analytical instrument, training, product & cycle development consultancy division that services an international client base
- Freeze drying equipment sales and consultancy services exclusively for our French speaking clients
- A dedicated USA division for R&D/analysis services, analytical instruments and freeze drying technology training requirements.
Cambridge Design Partnership
Cambridge Design Partnership is a technology and product design partner focused on helping clients grow their businesses. Our experts in engineering, quality assurance, regulation, human factors and industrial design offer a unique end-to-end service – from front-end innovation, through design and development, to manufacturing. As specialists in drug delivery device development, certified to ISO 13485, we can ensure your next product is patient focused and commercially effective – optimising the value of your investment in innovation.
DuPont Nutrition & Health
With combined decades of technical and industry expertise, DuPont, Dow, and FMC are unifying their product offerings, which service the food, pharmaceutical, and nutraceutical markets under the name DuPont Nutrition & Health. This newly combined portfolio addresses the toughest challenges its customers face in pharmaceutical applications, drug delivery systems, and productivity enhancement.
Enable Injections
The enFuse®, developed and manufactured by Enable Injections, is designed to enable user-administered subcutaneous delivery of high-volume therapeutics outside of a healthcare facility.
Bio-pharma companies collaboratively partner with Enable Injections to differentiate their portfolios with an ultimate development goal of empowering patients to achieve improved outcomes.
Enable employees are technology experts focused on an exceptional patient experience in collaboration with our bio-pharma partners.
Frontage
Frontage is a full service CRO which closely collaborates with pharmaceutical and biotech companies to help them bring promising drug candidates to market. With 14 locations in USA and China, Frontage has been assisting clients in their drug development efforts since 2001. Spanning from preclinical through late-stage development, its full service offerings include DMPK, Bioanalytical Services for Small and Large Molecule and Biomarkers, CMC, Early Stage Clinical Services and Full Biometrics Support. Frontage also provides turnkey product development services to generic, innovator and consumer health companies to support IND, NDA, ANDA, and 505(b)(2) submissions. What sets us apart is our ability to collaborate closely with our clients to ensure a deep understanding of their drug development goals and our ability provide flexible solutions that are customized to each client’s needs. At Frontage, we are committed to providing rigorous scientific expertise to ensure the highest quality and compliance on each project. Frontage proudly serves innovator, generic and consumer health companies from IND enabling through late stage clinical projects. Frontage successfully assists clients to advance hundreds of molecules through development to commercial launch in global markets. This partnership with our clients is how we turn services into real solutions that get our clients ahead.
Integrity Bio
Integrity Bio is a contract development organization focused on the formulation and GMP filling of biologics. We have formulated over 200 biologics including vaccines, antibodies, proteins, and peptides for more than 100 firms. Integrity specializes in hard-to-formulate products in liquid and lyophilized forms.
Additionally, Integrity Bio has developed proprietary products to solve development challenges or extend the product lifecycle. For lyophilized products, Integrity offers LyoTip, a simple to use reconstitution system that allows one step reconstitution and injection without complex mixing and set up procedures.
Integrity has also patented EXCELSE technology that can stabilize, lower viscosity, and safely concentrate biologics.
KAER Biotherapeutics
KAER Biotherapeutics’ SUPRAER technology enables rapid aerosol therapy of respiratory conditions with biotherapeutics, antibiotics and anticancer agents within a clinical setting. SUPRAER aerosolizes aqueous viscous (up to 40 cP) solutions/suspensions of high molecular weight entities and efficiently delivers them as pure fine particle (1.5 - 4 microns) solid-phase aerosols at concentrations up to and exceeding 2 mg/l with delivered doses up to 2 gm in 10 minutes. These aerosols in a low pressure gas stream contain 20-30 times the mass of drug per particle compared to similar sized aqueous aerosol. As excipients are not required, formulation costs are reduced and any untoward side effects eliminated. The ability to deliver clinically relevant doses of therapeutics in a short treatment time improves patient and clinician acceptance, reduces personnel costs and leads to better outcomes. KAER’s internal programs are focused on non-invasive surfactant aerosol therapy for patients with respiratory distress precipitated by inadequate surfactant to sustain proper respiratory function - premature babies and patients with acute lung injury. SUPRAER can provide continuous positive airway pressure, CPAP, for neonates and CPAP or bilevel pressure ventilation for adult patients, thus averting the need to interface the device with a separate ventilator. Over 50% of the generated aerosol is administered to the respiratory tract of the patient. SUPRAER technology opens new treatments to patients with pulmonary fibrosis, pneumonia, COPD, atelectasis, cystic fibrosis, severe asthma hospital-acquired lung infections and lung cancer.
Patheon, part of Thermo Fisher Scientific
Thermo Fisher Scientific’s Patheon and Fisher Clinical Services brands provide industry-leading solutions for drug development, clinical trial logistics and commercial manufacturing to customers of all sizes. With more than 40 locations around the world, the company can provide integrated, end-to-end capabilities across all phases of development, including API, biologics, formulation, clinical trials solutions and commercial manufacturing.
Roquette
ROQUETTE “Improving well-being by offering the best of nature” A family-owned Group serving customers globally, Roquette is a leader in specialty food ingredients and pharmaceutical excipients. The products and solutions developed by the Group deliver proven technological, nutritional and health benefits precisely tailored to the pharma, nutrition, food and selected industry markets. Roquette’s offer is produced from plant based raw materials such as corn, wheat, potatoes and peas. Since its foundation over 80 years ago, the Group’s growth has been based on innovation, a passion for the job and a commitment to achieve. Roquette operates in over 100 countries, has a turnover of around 3.3 billion euros and currently employs more than 8,000 people worldwide.
Solvay
Solvay is a global partner for pharmaceutical companies offering solubilizing, wetting, dispersing, emulsifying agents and tablet manufacturing aids. Solvay, the world's leading supplier of Docusate, manufactures pharmaceutical grade products to the highest quality standards under current good manufacturing practices (cGMP), and is the holder of a USA Drug Master File (DMF) for Docusate. From granulation, to hot-melt extrusion and nano-milling, Solvay has developed functional excipients to support the most challenging solubilization issues.
Unchained Labs
Here’s the deal. We’re all about helping biologics researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
West Pharmaceutical Services
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2017 net sales of $1.6 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.
Credence MedSystems
Credence MedSystems is setting a new standard in drug delivery, helping our pharmaceutical customers differentiate their products through innovative delivery systems while preserving their trusted processes.
Upperton Pharma Solutions
Upperton Pharma Solutions is a specialist CDMO providing spray drying and formulation services. We offer our clients a complete development package, encompassing: early feasibility studies, process optimisation, scale up and clinical trial (GMP) manufacturing. We have experience of working with a range of dosage forms and the expertise to overcome complex delivery challenges, for small molecules or complex biotherapeutics. Our formulation work is supported by a comprehensive range of analytical capabilities. Upperton has an extensive, multinational client-base, ranging from small start-ups to global pharma companies and we pride ourselves on our client-focus, flexible approach and scientific excellence.
Precision Nanosystems
Precision NanoSystems Inc (PNI) creates innovative solutions for the discovery, development and manufacture of medicines and medical research. PNI’s proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.
LTS Lohmann
LTS is the global leader in the development and manufacture of transdermal systems and oral thin films with additional innovative technologies in development. The products developed by LTS comprise a multitude of innovations, such as first and only patch for treatment of Alzheimer and the only patch against Parkinson’s and Restless-Legs-Syndrome, which is the first medication in the world available only as a patch. The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS supports its cooperation partners from product inception through commercialization in our FDA approved facilities in Germany and USA. More than 3,000 patents reinforce the top position of LTS group in development of its technologies. LTS Lohmann services include: Feasibility studies Full product development Clinical studies phase I-IV Scale-up and process development Commercial manufacturing For transdermal therapeutic systems, topical patches and oral thin films (OTF)
Tesa Labtec
BY YOUR SIDE - FROM IDEA TO MARKET
We are your full service CDMO for transdermal patches and oral films.
As our customer, you may expect premium quality and full regulatory compliance. We allow you to reduce the number of contractors you currently work with and handle all steps of drug development and manufacturing. Our products are made in Germany, safeguarded by our quality systems under full cGMP in high quality. Considering the many changes affecting our industry, we fully comprehend your need for end-to-end services and are available as your reliable partner.
Redshift Bioanalytics
RedShiftBio is the developer of Microfluidic Modulation Spectroscopy (MMS). MMS addresses the limitations of current protein characterization technologies and provides direct, label-free protein analysis. It uses a tunable mid-infrared quantum cascade laser to generate an optical beam 1000 times brighter than those used in conventional FTIR, enabling the measurement of more concentrated samples, and the use of simpler detectors with no requirement for nitrogen cooling. The unique optical configuration of MMS delivers high sensitivity measurements over a wide concentration range of 0.1 – 200 mg/mL to 0.01 mg/mL, giving MMS a wider dynamic range than alternative protein characterization techniques.
Sorrel Medical
Sorrel Medical is a medical device company focused on the development and manufacturing of pre-filled wearable injectors for the easy and efficient self-administration of large volume and high viscosity medications. One of three privately held companies operating under the Eitan Group, Sorrel leverages core capabilities and expertise in drug delivery technology development, manufacturing and regulatory experience to offer a robust platform solution to the healthcare market. With innovative technology solutions, Sorrel's devices address the need for partner-oriented and patient-centric drug delivery systems
Micropore
Micropore Technologies specializes in membrane emulsification and encapsulation process equipment used in pharmaceutical formulation and manufacturing. Our patented technology offers superior control in the production of monodispersed particles, while using lower energy and less shear which can help to preserve sensitive API's and biologics. Micropore also offers formulation consultancy and feasibility studies across a wide array of encapsulation techniques.
Emergent BioSolutions
Emergent BioSolutions provides contract manufacturing services for both bulk drug substances and sterile injectable drug products. Our state-of-the-art, single-use BDS facility enables turnkey upstream and downstream support for microbial, mammalian, and viral cell lines. Our Fill/Finish services include vials and syringes for both liquid and lyophilized products. We also offer lyo cycle development and optimization. Our global manufacturing network currently produces over 30 commercial products and supports a host of clinical stage programs.
For nearly 20 years, Emergent has been dedicated to the quality of services and safety of our products for our customers in effort to create a healthier world.
For more information refer to our website here: www.ebsi.com/CMO
Intertek
For more than 130 years, companies around the world have depended on Intertek to help ensure the quality and safety of their products, processes and systems.
DPT Labs
As the leading contract development and manufacturing organization (CDMO), DPT, a Mylan company, is recognized for our expertise in semi-solid and liquid dosage forms, with an established legacy of excellence dating back more than 80 years.
More than any other CDMO, we understand how scale-up will be interwoven from your research and development project into full-scale commercialization, offering close consultation throughout your product’s life cycle. From pre-formulation to commercial manufacturing, you only need one partner to streamline your path from lab to market: DPT does it all.
Development Services:
- Pre-formulation and formulation
- Analytical development and validation
- Process development and validation
- Stability studies: ICH and custom
- Clinical trial material manufacturing
- In vitro release testing expertise
- Quality-by-Design